跳至主要内容
临床试验/NCT03121482
NCT03121482已完成不适用

High-flow Nasal Cannula Oxygen Therapy With or Without Non-invasive Ventilation (NIV) During the Weaning Period: a Multicenter Randomized Controlled Trial

Poitiers University Hospital2 个研究点 分布在 1 个国家目标入组 650 人开始时间: 2017年4月20日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
650
试验地点
2
主要终点
Reintubation at Day 7

研究概览

简要总结

Prospective multicenter randomized controlled open-label trial comparing 2 strategies of oxygenation during the post-extubation period in ICU patients at high risk of extubation failure. Patients will be randomized and assigned to one of the two groups, with a 1:1 ratio.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Duration of mechanical ventilation prior to extubation at least 24h
  • Planned extubation decided by the physician in charge of the patient after success of a weaning trial
  • Patients at high risk of reintubation according to the following criteria: patients older than 65 years, or those having any underlying chronic cardiac or lung disease.

排除标准

  • Patient admitted for traumatic brain injury
  • Periphal neuromuscular disease as reason for intubation
  • Usual lon-term treatment with NIV for chronic desease
  • Usual lon-term treatment with CPAP for obstructive apneas syndrome
  • Contraindication to NIV
  • Unplanned extubation
  • Do-not-reintubated order at time of extubation
  • Terminal extubation for end of life
  • People under legal protection
  • Opposition to participate

研究组 & 干预措施

HFNC and NIV

Experimental

干预措施: HFNC (Device)

HFNC and NIV

Experimental

干预措施: NIV (Device)

HFNC alone

Active Comparator

Control group

干预措施: HFNC (Device)

结局指标

主要结局

Reintubation at Day 7

时间窗: up to 7 days

The rate of reintubation will be assessed within the 7 days following planned extubation

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验